Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to evaluate the effectiveness of two treatment regimens by assessing the average BCVA change from Month 4 to Month 12 compared to Month 3 based on both, BCVA stability in each treatment group and comparison of the two treatment groups. For the analysis of these objectives a reference margin of two letters will be applied. A treatment regimen will be considered a relevant option if stability is achieved and non-inferiority compared to the other group is demonstrated.
Critère d'inclusion
- Visual impairment due to neovascular AMD